Zenas BioPharma, Inc. (ZBIO)
Zenas BioPharma, Inc. (ZBIO) has reported earnings 7 times since Nov 12, 2024. The stock moves an average of ±4.94% the day after reporting, closing higher 71.4% of the time. Its largest post-earnings gain was +12.21% (May 15, 2025) and its largest decline was -3.37% (Mar 16, 2026). The next earnings report is predicted for 2026-08-12 (estimated).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
7
Avg Abs. Movement
±4.94%
Positive %
71.4%
Negative %
28.6%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 13, 2026 | ☀ PRE | $19.52 | $20.22 | $19.96 | 23,572 | +4.15% | open_in_new |
| Mar 16, 2026 | ☀ PRE | $23.35 | $24.02 | $23.23 | 600,600 | -3.37% | open_in_new |
| Nov 12, 2025 | ☀ PRE | $36.00 | $36.63 | $35.80 | 252,400 | +1.7% | open_in_new |
| Aug 12, 2025 | ☀ PRE | $14.51 | $16.17 | $15.90 | 98,000 | +6.68% | open_in_new |
| May 15, 2025 | ☀ PRE | $9.12 | $10.03 | $9.74 | 195,800 | +12.21% | open_in_new |
| Feb 05, 2025 | ☀ PRE | $7.54 | $8.04 | $7.92 | 209,500 | +3.39% | open_in_new |
| Nov 12, 2024 | ☀ PRE | $21.08 | $22.48 | $20.61 | 77,900 | -3.1% | open_in_new |
Earnings Count
7
Total earnings in dataset
Avg Abs. Movement
±4.94%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260518 | open_in_new SEC.gov |
| 10-Q | 20260513 | open_in_new SEC.gov |
| 8-K | 20260513 | open_in_new SEC.gov |
| SCHEDULE 13D | 20260505 | open_in_new SEC.gov |
| 4 | 20260429 | open_in_new SEC.gov |
| 4 | 20260429 | open_in_new SEC.gov |
| SCHEDULE 13D/A | 20260402 | open_in_new SEC.gov |
| 4 | 20260402 | open_in_new SEC.gov |
| 4 | 20260401 | open_in_new SEC.gov |
| 4 | 20260331 | open_in_new SEC.gov |
Frequently asked about ZBIO earnings
When does Zenas BioPharma, Inc. report earnings next? expand_more
Zenas BioPharma, Inc. (ZBIO)'s next earnings date is estimated for 2026-08-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does ZBIO stock move after earnings? expand_more
Over 7 reports, ZBIO has moved an average of ±4.94% the session after earnings, closing higher 71.4% of the time.
What was ZBIO's biggest post-earnings move? expand_more
ZBIO's largest post-earnings gain on record was +12.21% on May 15, 2025, and its largest decline was -3.37% on Mar 16, 2026.
Where can I find Zenas BioPharma, Inc.'s SEC filings? expand_more
All of Zenas BioPharma, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right